|
1.
Isles MG, McConkey C, Mehanna
HM. A systematic review
and meta-analysis of the
role of positron emission
tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol.
2008;33:210-22.
http://dx.doi.org/10.1111/j.1749-4486.2008.01688.x
|
|
|
|
2.
Fischbein NJ, AAssar
OS, Caputo GR, Kaplan MJ, Singer MI, Price DC, et
al. Clinical utility of
positron emission tomography with
18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head
and neck. AJNR Am J Neuroradiol.
1998;19:1189-96.
|
|
|
|
|
3.
Seitz O, Chambron-Pinho
N, Middendorp M, Sader
R, Mack M, Vogl TJ, et
al. 18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease,
and gross tumor volume
of oropharyngeal and oral cavity
cancer: comparison with MR imaging and-validation with surgical specimen. Neuroradiology. 2009;51:677-86.
http://dx.doi.org/10.1007/s00234-009-0586-8
|
|
|
|
|
4.
Roh JL, Yeo NK, Kim JS,
Lee JH, Cho KJ, Choi
SH, et al. Utility of 2-[18F]
fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral
Oncol. 2007;43:887-93.
http://dx.doi.org/10.1016/j.oraloncology.2006.10.011
|
|
|
|
|
5.
Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, et al. Prospective
study of [18F]fluorodeoxyglucose
positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol. 2006;24:4371-6.
http://dx.doi.org/10.1200/JCO.2006.05.7349
|
|
|
|
|
6.
Pasha MA, Marcus C, Fakhry
C, Kang H, Kiess AP, Subramaniam RM. FDG PET/CT for
management and assessing
outcomes of squamous cell cancer of the oral cavity. Am J Roentgenol. 2015;205:150-61.
http://dx.doi.org/10.2214/AJR.14.13830
|
|
|
|
|
7.
Kito S, Koga H, Kodama M, Yamamoto N, Kokuryo S, Habu M, et al. Reflection of 18F-FDG accumulation
in the evaluation of the extent of periapical or periodontal inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:e62-9.
http://dx.doi.org/10.1016/j.oooo.2012.05.027
|
|
|
|
|
8.
McGarvey AC, Osmotherly
PG, Hoffman GR, Chiarelli PE. Scapular
muscle exercises following neck dissection surgery for head and neck cancer: a comparative electromyographic study. Phys Ther. 2013;93:786-97.
http://dx.doi.org/10.2522/ptj.20120385
|
|
|
|
|
9.
McGarvey AC, Osmotherly
PG, Hoffman GR, Chiarelli PE. Impact
of neck dissection on scapular muscle function: a case-controlled electromyographic study. Arch Phys Med Rehabil.
2013;94:113-9.
http://dx.doi.org/10.1016/j.apmr.2012.07.017
|
|
|
|
|
10.
McGarvey AC, Chiarelli
PE, Osmotherly PG, Hoffman GR. Physiotherapy for accessory nerve shoulder dysfunction following neck dissection surgery: a literature review. Head Neck. 2011;33:274-80.
http://dx.doi.org/10.1002/hed.21366
|
|
|
|
|
11.
Andreadis D, Stylianou
F, Link-Tsatsouli I, Markopoulos
A. Bilateral masseter and internal
pterygoid muscle hypertrophy: a diagnostic challenge. Med Princ Pract. 2014;23:286-8.
http://dx.doi.org/10.1159/000354099
|
|
|
|
|
12.
Ariji Y, Fuwa N, Kodaira T, Tachibana H, Nakamura T, Satoh Y, et al.
False-positive positron emission
tomography appearance with 18F-fluorodeoxyglucose after
definitive radiotherapy
for cancer of the mobile tongue. Br J Radiol.
2009;82:e3-7.
http://dx.doi.org/10.1259/bjr/96087474
|
|
|
|
|
13.
Kito S, Koga H, Kodama M, Habu M, Kokuryo S, Yamamoto N, et al.
Variety and complexity
of fluorine-18-labelled fluoro-2-deoxy-D-glucose accumulations
in the oral cavity of patients with oral cancers. Dentomaxillofac Radiol. 2013;42:20130014.
http://dx.doi.org/10.1259/dmfr.20130014
|
|
|
|
|
14.
Miyashita G, Higuchi T, Oriuchi
N, Arisaka Y, Hanaoka
H, Tominaga H, et al. 18F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with 18F-FDG PET and immunohistochemistry. Ann Nucl
Med. 2010;24:579-84.
http://dx.doi.org/10.1007/s12149-010-0398-2
|
|
|
|
|
15.
Miyawaki A, Ikeda R, Hijioka H, Ishida T, Ushiyama M, Nozoe E, et al. SUVmax of FDG-PET correlates with the effects
of neoadjuvant chemoradiotherapy
for oral squamous cell carcinoma. Oncol Rep.
2010;23:1205-12.
http://dx.doi.org/10.3892/or_00000751
|
|
|
|
|
16.
Schwartz DL, Ford E, Rajendran J, Yueh B, Coltrera MD, Virgin J, et al. Laramore GE.
FDG-PET/CT imaging for preradiotherapy staging of
head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:129-36.
http://dx.doi.org/10.1016/j.ijrobp.2004.03.040
|
|
|
|
|